Opposite effects of M. leprae or M. bovis BCG delipidation on cellular accumulation into mouse pleural cavity. Distinct accomplishment of mycobacterial lipids in vivo

Inflammation Research

Volumn 48, Issue 6, 1999, Pages 308-313

  Moura, A C N ^a   Leonardo, P S ^b   Henriques, M G M O ^b   Cordeiro, R S B ^a  

^a Universidade Do Estadodo Rio de Janeiro   (Brazil)

^b NONE

Author keywords

BCG; Cell migration; Macrophage; Mycobacterial lipids; Pleurisy

Indexed keywords

BCG VACCINE; MEMBRANE LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL WALL; CELL INFILTRATION; CONTROLLED STUDY; EOSINOPHIL; LEUKOCYTE COUNT; MALE; MONONUCLEAR CELL; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; NEUTROPHIL; NONHUMAN; PLEURA CAVITY; PLEURISY; STATISTICAL ANALYSIS;

ANIMALS; CELL WALL; CHEMOTAXIS, LEUKOCYTE; EOSINOPHILS; LEUKOCYTES, MONONUCLEAR; MEMBRANE LIPIDS; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; NEUTROPHILS; PLEURA; PLEURISY;

EID: 0032796521     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050465     Document Type: Article

References (36)

1. Sibley LD, Krahenbuhl JL. Induction of unresponsiveness to gamma interferon in macrophages infected with Mycobacterium leprae. Infect Immun 1988; 36: 1912-9.
2. Appelberg R, Soares S, Ferreira P, Silva MT. Induction of non-specific immuno-suppression in mice by mycobacterial infections and its relationship to macrophage activation. Scand J Immunol 1989; 30: 165-74.
3. Sengupta U. Cell-mediated immunity in leprosy; an update. Int J Lepr Other Mycobact Dis 1993; 61: 439-54.
4. Ottenhof THM. Immunology of leprosy. Lessons from and for leprosy. Int J Lepr Other Mycobact Dis 1994; 62: 108-21.
5. Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Mazzaccaro RJ, Soriano T, et al. CD1-restricted T cell recognition of microbial antigens. Science 1995; 269: 227-9.
6. Choudhuri K. The immunology of leprosy; an unraveling enigma. Int J Lepr Other Mycobact Dis 1995; 63: 430-47.
7. Rook GAW, Hernandez-Paulo R. The pathogenesis of tuberculosis. Ann Rev Microbiol 1996; 50: 259-84.
8. Xu S, Cooper A, Sturgill-Koszycki S, van Heyningen T, Chatterjee D, Orme P, et al. Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. J Immunol 1994; 153: 2568-78.
9. Silva CL, Ekizlerian SM, Fazioli RA. Role of cord factor in the modulation of infection caused by Mycobacteria. Am J Pathol 1985; 118: 238-47.
10. Tomioka H, Kishimoto T, Maw WW. Phospholipids and reactive nitrogen intermediates collaborate in expression of the T cell mitogenesis-inhibitory activity of immunosupppressive macrophages induced in mycobacterial infection. Clin Exp Immunol 1996; 103: 219-25.
11. Shepard CC. The experimental disease that follows the injection of human leprosy bacilli into mouse foot-pads of mice. J Exp Med 1960; 112: 445-54.
12. Moura ACN, Mariano M. Dead Mycobacterium leprae inhibits phagocytosis by inflammatory macrophages in vivo. Participation of the bacteria cell wall lipids in the phenomenon. Mem Inst Oswaldo Cruz 1990; 85: 381-2.
13. Moura ACN, Mariano M. Mycobacterium leprae cell wall lipids are endowed with anti-inflammatory activity. Immunology 1996; 89:613-8.
14. Moura ACN, Werneck-Barroso E, Sampaio ALF, Cordeiro RSB, Henriques MGMO. Mycobacterium leprae and Mycobacterium bovis - BCG evoke distinct inflammatory response in mice pleurisy. Inflamm Res 1995; 44(Suppl): 288.
15. Menezes-de-Lima O Jr, Werneck-Barroso O, Cordeiro RSB, Henriques MGMO. Effects of inhibitors of inflammatory mediators and cytokines on the cosinophil and neutrophil accumulation induced by Mycobacterium bovis BCG in mouse pleurisy. J Leukoc Biol 1997; 62: 778-85.
16. Moura ACN, Modolell M, Mariano M. Down-regulatory effect of Mycobacterium leprae cell wall lipids on phagocytosis, oxidative respiratory burst and tumor cell killing by mouse bone marrow-derived macrophages. Scand J Immunol 1997; 46: 375-80.
17. Moura ACN, Mariano M. Lipids from Mycobacterium leprae cell wall suppress T cell activation in vivo and in vitro. Immunology 1997; 92: 366-73.
18. Berman JS, Blumenthal ARL, Kornfeld H, Cook JA, Cruikshank WW, Vermeulen MW, et al. Chemotatic activity of mycobacterial lipoarabinomannans for human blood T lymphocytes in vitro. J Immunol 1996; 156: 3828-3835.
19. Liu J, Rosenberg Y, Nikaido H. Fluidity of the lipid domain of cell wall from Mycobacterium chelonae. Proc Natl Acad Sci USA 1995; 92: 11254-8.
20. Mikusová K, Slayden RA, Besra GS, Brennan PJ. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob Agents Chemother 1995; 39: 2484-9.
21. Moura AC, Werneck-Barroso E, Rosas EC, Henriques MG, Cordeiro ARS. Opposite cellular accumulation and nitric oxide production in vivo after pleural immunization with M. leprae or M. bovis BCG. Int J Mol Med 1999; 3: 69-74.
22. Oswald IP, Afroun S, Bray D, Petit J-F, Lemaire G. Low response of BALB/c macrophages to priming and activating signals. J Leukoc Biol 1992; 52: 315-22.
23. γ and infection with BCG. Immunology 1994; 82: 457-64.
24. Bloch H. Studies on the virulence of tubercle bacilli. Isolation and biological properties of a constituent of virulent organisms J Exp Med 1950; 91: 197-217.
25. Henriques MGMO, Weg VB, Martins MA, Silva PMR, Fernandes PD, Cordeiro RSB, et al. Differential inhibition by two hetrazepine PAF antagonists of acute inflammation in the mouse. Br J Pharmacol 1990; 99: 164-8.
26. Penido C, Faria-Neto HCC, Larangeira AP, Rosas EC, Ribeiro-Dos-Santos R, Bozza PT, et al. The role of gammadelta T lymphocytes in lipopolysaccharide-induced cosinophil accumulation into the mouse pleural cavity. J Immunol 1997; 159: 853-60.
27. Zlotnik A, Crowle AJ. Lymphokine-induced mycobacteriostatic activity in mouse pleural macrophages. Infect Immun 1982; 17: 786-93.
28. Yang J, Kawamura I, Zhu H, Mitsuyama M. Involvement of natural killer cells after stimulation with Mycobacterium bovis BCG. Study of the mechanism of the different abilities of viable and killed BCG. J Immunol 1995; 155: 5728-35.
29. Zhang L, Goren MG, Holzer TJ, Andersen BR. Effect of Mycobacterium tuberculosis sulfolipid I on human phagocytic cells. Infect Immun 1988; 56: 287-883.
30. Spector WG. The mediation of altered capillary permeability in acute inflammation. J Pathol Bact 1956; LXXII.
31. Baumann MH, Heirich K, Sahn AS, Green C, Harley R, Strange C. Electron microscopic analysis of the normal and the activated pleural macrophage. Exp Lung Res 1993; 19: 731-42.
32. Zlotnik A, Vatter A, Hayes R, Blumenthal B, Crowle AJ. Mouse pleural macrophages: characterization and comparison with mouse alveolar and peritoneal macrophages. J Reticuloendothel Soc 1982; 31: 207-20.
33. Young DB, Lathigra R, Hendrix R, Sweetser D, Young RA. Stress proteins are immune targets in leprosy and tuberculosis. Proc Natl Acad Sci USA 1988; 85: 4267-270.
34. Scherman M, Weston A, Duncan K, Whittington A, Upton R, Deng L, et al. Biosynthetic origin of mycobacterial cell wall arabinosyl residues. J Bacteriol 1995; 177: 7125-30.
35. Sut A, Siruge S, Sixou S, Lakhdar-Ghazal F, Tocanne JF, Lanéelle G. Mycobacteria glycolipids as potencial pathogenicity effectors: alteration of model and natural membranes. Biochemistry 1990; 29: 8498-502.
36. Vergne I, Prats M, Tocanne JF, Lanéelle AG. Mycobacterial glycopeptidolipid interactions with membranes: a monolayer study. FEBS Lett 1995; 375: 254-8.